nVNS for the Prevention and Treatment of Primary Headache

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 5, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

December 30, 2026

Conditions
Primary HeadacheMigraine in AdolescenceMigraine in ChildrenCluster HeadacheTension Headache
Interventions
DEVICE

Transcutaneous auricular vagus nerve stimulation

The vagus nerve's auricular branch is primarily distributed in the tragus, tragus sulcus, and concha cavity. It can activate the nucleus tractus solitarius through the vagus afferent fibers, thereby activating various areas of the vagus nerve in the central nervous system. This stimulation technique involves applying a constant current of around 2-3mA to the epidermal terminals of the ear using an electrode. It aims to regulate the vagus nerve, modulate the autonomic nervous system, release neurotransmitters, improve cerebral blood flow, and alleviate headache symptoms. In the implementation, non-invasive transcutaneous vagus nerve stimulation was performed by having the subject wear a vagus stimulator and adjusting the appropriate stimulation intensity.

Trial Locations (1)

Unknown

RECRUITING

Nanfang Hospital, Southern Medical University, Guangzhou

All Listed Sponsors
collaborator

BrainClos Company, LTD.

UNKNOWN

collaborator

Zhuhai Fudan Innovation Institute

UNKNOWN

lead

Nanfang Hospital, Southern Medical University

OTHER